Publication

Chemical genetic screen identifies Gapex-5/GAPVDI and STBD1 as novel AMPK substrates

Related publications (32)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Chemical genetic screen identifies Gapex-5/GAPVDI and STBD1 as novel AMPK substrates

Graph Chatbot

Chat with Graph Search

Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle

Imaging liver and brain glycogen metabolism at the nanometer scale

A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity

Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662

Metabolic modeling and experimental studies on carbon and energy metabolism of Mycobacterium tuberculosis

The activation of hepatic and muscle polyamine catabolism improves glucose homeostasis

GTPase Activity and Neuronal Toxicity of Parkinson's Disease-Associated LRRK2 Is Regulated by ArfGAP1

Calorie restriction: is AMPK a key sensor and effector?

Altered Glycogen Metabolism in Cultured Astrocytes from Mice with Chronic Glutathione Deficit; Relevance for Neuroenergetics in Schizophrenia

Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility